Cerebral palsy physiotherapu assessment and management give a short introduction and clinical

Reading File
Finding Sources
Finding Sources
Searching PubMed

"cerebral palsy"[MeSH Terms] AND "physical therapy"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Reading File
I now have comprehensive content. Let me compile the full answer.

Cerebral Palsy: Physiotherapy Assessment and Management

Introduction

Cerebral palsy (CP) is defined as a group of permanent disorders of the development of movement and posture, causing activity limitation, attributed to non-progressive disturbances that occurred in the developing fetal or infant brain (Rosenbaum et al., 2007). Despite the underlying brain lesion being static (non-progressive), the clinical expression changes dynamically with growth and aging - making CP better understood as an evolving condition rather than a truly "static" one.
To diagnose CP, five criteria must be met:
  1. A disorder of movement and/or posture (weakness, spasticity, dystonia, ataxia, or choreoathetosis) with onset before age 1-2 years
  2. Reliable evidence of a fetal or infant brain disturbance
  3. No evidence of progression over time
  4. Significant functional limitation in activities
  5. Reasonable expectation the disorder persists lifelong
(Bradley and Daroff's Neurology in Clinical Practice)

Epidemiology and Causes

CP affects approximately 2-3 per 1,000 live births. Adults with CP now outnumber children by a ratio of 3:1 in many countries.
Congenital CP (85-90% of cases) results from brain injury before or during birth. Acquired CP (remaining ~10-15%) arises after the first month of life - most commonly from perinatal stroke (ischemic, hemorrhagic, or thromboembolic), followed by meningitis/encephalitis in infancy.
Key risk factors:
  • Prematurity (strongest single risk; incidence 8.7% in <32 weeks gestation vs. 0.6% in 34-37 weeks)
  • Very low birth weight (<1,500 g)
  • Periventricular/intraventricular hemorrhage
  • TORCH infections (Toxoplasmosis, Other, Rubella, CMV, Herpes)
  • Perinatal hypoxic-ischemic injury
  • Multiple gestations (largely mediated through prematurity)
(Bradley and Daroff's Neurology in Clinical Practice)

Classification

By Motor Type

TypeFeaturesPrevalence
SpasticVelocity-dependent increase in muscle tone, hyperreflexia, Babinski sign, clonus - upper motor neuron injury70-80%
DyskineticDystonia, chorea, athetosis, or combinations; due to basal ganglia injury~15%
Ataxic/HypotonicCerebellar or hypotonic features, balance and coordination deficits~5%
MixedCombination of the aboveVariable

By Topography (Spastic CP)

Topographical distribution in cerebral palsy showing monoplegia, hemiplegia, diplegia, triplegia, and quadriplegia
  • Monoplegia - one limb affected
  • Hemiplegia - one side (arm + leg), usually arm more than leg
  • Diplegia - legs predominantly, arms less so (classic in periventricular leukomalacia)
  • Triplegia - both legs and one arm
  • Quadriplegia - all four limbs plus trunk and face

Gross Motor Function Classification System (GMFCS)

A 5-level system used universally to classify functional mobility:
  • Level I: Walks without restrictions
  • Level II: Walks with limitations outdoors
  • Level III: Walks with assistive devices
  • Level IV: Self-mobility limited, uses powered wheelchair
  • Level V: Transported in manual wheelchair; no independent mobility
GMFCS IV/V patients carry a nearly 50% risk of developing spinal deformity (scoliosis).

Clinical Features

Upper Motor Neuron Syndrome

CP primarily produces features of UMN syndrome, which are divided into:
Positive features (targetable with intervention):
  • Spasticity
  • Clonus
  • Hyperreflexia with radiation
  • Extensor/flexor spasms
  • Positive Babinski sign
  • Involuntary activation of remote muscles
Negative features (more causative of disability, less responsive to treatment):
  • Muscle weakness
  • Loss of selective motor control
  • Loss of dexterity
  • Fatigability
  • Cognitive, communication, and behavioral changes
(Bradley and Daroff's Neurology in Clinical Practice)

Characteristic Postures and Gait Patterns

  • Upper limb: elbow flexion, wrist/finger flexion, shoulder internal rotation, forearm pronation
  • Lower limb: hip flexion and adduction, knee flexion, toe walking
  • Gait patterns: toe-walking, crouched gait, jump gait, scissor gait (hip adduction)

Associated Conditions

  • Epilepsy (30-50%)
  • Intellectual disability
  • Sensory impairments (vision, hearing)
  • Communication/speech difficulties
  • Feeding and swallowing dysfunction (sialorrhea common - may require physiotherapy measures, posture optimization, or botulinum toxin to submandibular ducts)
  • Depression (prevalence up to double the general population in adults, correlating with functional disability)
  • Cervical myelopathy in dyskinetic CP (onset typically 4th decade due to sustained involuntary movements causing degenerative changes)

Physiotherapy Assessment

A structured PT assessment follows a biopsychosocial framework using the ICF (International Classification of Functioning, Disability, and Health).

History

  • Pregnancy history: gestational age, birth weight, perinatal complications, NICU course
  • Developmental trajectory: motor, language, visual-motor milestones
  • Current functional abilities, assistive devices used
  • Pain complaints and fatigue (very common in adults)
  • Previous interventions: botulinum toxin, surgeries, orthoses

Physical Examination

1. Tone Assessment
  • Modified Ashworth Scale (MAS) or Tardieu Scale for spasticity
  • Distinguish spasticity (velocity-dependent) from dystonia (sustained abnormal postures) and rigidity
2. Range of Motion (ROM)
  • Passive and active ROM of all joints
  • Hip: Thomas test (hip flexion contracture), Ober test (IT band tightness), Staheli test (hip extension)
  • Knee: popliteal angle for hamstring tightness
  • Ankle: Silfverskiöld test (distinguishes gastrocnemius vs. soleus tightness)
  • Foot: Coleman block test (hindfoot flexibility in cavovarus)
3. Strength Assessment
  • Selective motor control (proximal and distal)
  • Manual muscle testing (often limited by poor cooperation in younger children)
  • Functional strength testing
4. Reflexes and Primitive Reflexes
  • Persistent primitive reflexes (ATNR, STNR, Moro) beyond expected integration age
  • Deep tendon reflexes: hyperreflexia typical
  • Babinski sign
5. Posture and Alignment
  • Static and dynamic postural control
  • Pelvic tilt, trunk alignment
  • Hip surveillance (radiographic hip migration percentage monitored regularly)
  • Spinal curves: scoliosis assessment (particularly GMFCS IV/V)
6. Gait Analysis
  • Clinical observational gait analysis
  • Instrumented 3D gait analysis (gold standard for surgical planning): assesses kinematics, kinetics, and EMG to identify pathological patterns and guide multi-level surgical decisions
  • Common patterns: equinus, crouch gait, jump gait, stiff-knee gait (rectus femoris overactivity)
7. Functional Assessments (Outcome Measures)
  • GMFCS - functional mobility classification
  • MACS (Manual Ability Classification System) - hand function
  • CFCS (Communication Function Classification System)
  • Gross Motor Function Measure (GMFM-66 or GMFM-88) - quantifies motor function and tracks change over time
  • Pediatric Evaluation of Disability Inventory (PEDI)
  • 6-Minute Walk Test - endurance in ambulatory patients

Physiotherapy Management

The overarching goal is to maximize function by improving biomechanics through tone management, addressing musculoskeletal deformities, and building strength. Treatment is best delivered in a multidisciplinary setting embedding rehabilitation within a patient-centered framework involving physiatry, orthopaedics, PT, OT, speech therapy, and primary care.
(Bradley and Daroff's Neurology in Clinical Practice)

1. Physiotherapy Techniques

Stretching and Passive ROM
  • Regular stretching to prevent/delay contracture formation
  • Sustained (static) stretching preferred for spastic muscles
  • Serial casting used for progressive contractures (commonly ankle, knee, elbow)
Strengthening
  • Progressive resistance training - shown to improve strength without worsening spasticity
  • Focus on weak antagonists (hip extensors/abductors, ankle dorsiflexors)
  • Task-specific training improves motor learning
Neurodevelopmental Treatment (NDT) / Bobath Approach
  • Facilitates normal movement patterns; inhibits abnormal reflex activity
  • Widely used but evidence base continues to evolve
Constraint-Induced Movement Therapy (CIMT)
  • Used in hemiplegic CP: constrains unaffected limb to force use of affected arm
  • Good evidence for improving upper limb function in hemiplegia
Treadmill and Gait Training
  • Partial body-weight-supported treadmill training
  • Robotics-assisted gait training (Lokomat) in non/low-ambulatory patients
  • Improves walking speed, endurance, and GMFM scores
Hydrotherapy
  • Warm water reduces muscle tone temporarily, allowing improved ROM and movement
  • Useful for strengthening in reduced gravity environment
Functional Electrical Stimulation (FES)
  • Peroneal nerve FES for foot drop/equinus
  • Improves dorsiflexion during gait

2. Orthotic Management (PT co-managed)

  • Ankle-Foot Orthoses (AFO) - most commonly used; prevents equinus, supports walking
    • Solid AFO, hinged AFO, ground reaction AFO (for crouch gait)
  • Knee-Ankle-Foot Orthoses (KAFO) - for more proximal weakness
  • Hip abduction orthoses - in early hip subluxation
  • Upper limb splints - wrist/hand in hemiplegic CP

3. Pharmacological Management (PT works alongside)

Oral Medications for Diffuse Spasticity
  • Baclofen (first-line) - GABA-B agonist
  • Tizanidine, dantrolene, benzodiazepines (diazepam)
  • Second-line: clonidine or gabapentin (dual benefit for tone and sleep, pain, dysautonomia)
Focal Spasticity - Chemodenervation
  • Botulinum Toxin A (BoNT-A) - gold standard for focal spasticity
    • Injections every 4-6 months (minimum 3 months to avoid resistance)
    • Targets specific overactive muscles (e.g., gastrocnemius, hip adductors, rectus femoris)
    • Maximally effective when combined with physiotherapy immediately post-injection
  • Phenol / Ethyl alcohol - nerve blocks for larger muscle groups
Intrathecal Baclofen (ITB)
  • For severe, widespread spasticity not adequately controlled with oral baclofen
  • Delivers baclofen directly to CSF at a fraction of the oral dose
  • Avoids systemic side effects (sedation, weakness, GI symptoms)
  • Reversible (unlike SDR)
  • Requires test dose before pump implantation

4. Surgical Management (PT role: pre/post-op rehab)

Soft Tissue Procedures
  • Tendon lengthening/release (gastrocnemius-soleus, hamstrings, hip flexors, adductors)
  • Tendon transfers (e.g., split anterior tibialis transfer - SPLATT - for spastic varus)
  • Rectus femoris transfer/release for stiff-knee gait
Bony Procedures
  • Femoral/tibial derotation osteotomies for rotational malalignment
  • Hip reconstruction (varus derotation osteotomy + acetabuloplasty) for subluxation/dislocation
Selective Dorsal Rhizotomy (SDR)
  • Surgical sectioning of sensory nerve rootlets (L1-S1) reducing spastic input
  • Best candidates: spastic diplegia, GMFCS II-III, age 4-8 years, no fixed contractures
  • Produces permanent, significant spasticity reduction
  • Intensive post-operative PT for 12-24 months is mandatory
Spinal Fusion for Scoliosis
  • Indicated for curves >50 degrees in skeletally immature or progressive curves
  • Posterior instrumentation with pedicle screws; pelvic fixation preferred for pelvic obliquity
  • Complication rates reported up to 81% (infection 15-19%); pulmonary management is critical perioperatively
(Campbell's Operative Orthopaedics 15th Ed 2026; Bradley and Daroff's Neurology in Clinical Practice)

Adult Considerations in CP

  • Gait and self-care worsen in a substantial proportion of adults
  • Pain and fatigue are frequent complaints (multifactorial: hypertonia, musculoskeletal changes, reduced rehabilitation access)
  • Dyskinetic CP is complicated by cervical spine degeneration and myelopathy (onset ~4th decade)
  • Depression prevalence up to double the general population
  • Orthopedic interventions become less important once the skeleton matures; tone management and seizure management remain lifelong priorities

Summary Table: Physiotherapy Framework

DomainAssessment ToolsInterventions
ToneModified Ashworth Scale, Tardieu ScaleStretching, casting, BoNT-A, oral baclofen
ROM/ContractureGoniometry, Silfverskiöld, Thomas testSerial casting, SDR, tendon surgery
StrengthMMT, dynamometryResistance training, FES
GaitObservational + 3D gait analysisTreadmill training, BWSTT, AFOs
FunctionGMFM, MACS, PEDI, 6MWTTask-specific therapy, CIMT
Posture/SpineSpinal X-ray, GMFCSSeating systems, bracing, spinal fusion
Upper limbMACS, grip strengthCIMT, splints, OT

Sources: Bradley and Daroff's Neurology in Clinical Practice; Campbell's Operative Orthopaedics 15th Ed 2026; Miller's Review of Orthopaedics 9th Ed; Bailey and Love's Short Practice of Surgery 28th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.